Method of treating high plasma cholesterol levels
OwnerPaul Hadvary, Hans Lengsfeld +1inventors
InventorsPaul Hadvary, Hans Lengsfeld, Hans Steffen
Life of this patent
Estimating the term…
Abstract
A method prevents or treats diseases associated with high plasma cholesterol levels. In addition, this method reduces plasma cholesterol levels. The method comprises administering a lipase inhibitor, e.g. orlistat, and a pharmaceutically acceptable bile acid sequestrant.
Claims10
A method of reducing plasma cholesterol levels in a hypercholesterolemic patient, which comprises orally administering to the patient a therapeutically effective amount of orlistat and a therapeutically effective amount of between 0.1 and 20 grams per day of β-cyclodextrin or γ-cyclodextrin, wherein the orlistat and β-cyclodextrin or γ-cyclodextrin are administered during a meal or one to two hours before or after a meal.
A method of reducing plasma cholesterol levels in a hypercholesterolemic patient, which comprises orally administering to the patient a therapeutically effective amount of orlistat and a therapeutically effective amount of between 0.1 and 20 grams per day of colesevelam, wherein the orlistat and colesevelam are administered during a meal or one to two hours before or after a meal.
A method of reducing plasma cholesterol levels in a hypercholesterolemic patient, which comprises orally administering to the patient a therapeutically effective amount of orlistat and a therapeutically effective amount of between 0.1 and 20 grams per day of colestimide, wherein the orlistat and colestimide are administered during a meal or one to two hours before or after a meal.
Dependencies are inferred from the claim text.